| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.BJC.6604908 |
| P8608 | Fatcat ID | release_yllw6l2tmfgrvlyvkpgxqkjyb4 |
| P932 | PMC publication ID | 2653775 |
| P698 | PubMed publication ID | 19190630 |
| P5875 | ResearchGate publication ID | 23974882 |
| P50 | author | Rachel Neale | Q39939011 |
| Nirmala Pandeya | Q54997520 | ||
| James Doecke | Q56704968 | ||
| P2093 | author name string | Australian Cancer Study | |
| A C Green | |||
| S Sadeghi | |||
| P M Webb | |||
| D C Whiteman | |||
| P2860 | cites work | Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study | Q24684767 |
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry | Q30670859 | ||
| Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia | Q34744904 | ||
| A case-control study of oesophageal adenocarcinoma in women: a preventable disease | Q36641791 | ||
| Abdominal obesity and the risk of esophageal and gastric cardia carcinomas | Q37163349 | ||
| Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia | Q43519379 | ||
| Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus | Q45047199 | ||
| Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden | Q47576910 | ||
| Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms | Q49186689 | ||
| Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. | Q50661717 | ||
| Trends in obesity and energy supply in the WHO MONICA Project | Q58390870 | ||
| Rising incidence of adenocarcinoma of the esophagus and gastric cardia | Q68199481 | ||
| Leptin expression in colorectal and breast cancer patients | Q73552947 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 795-798 | |
| P577 | publication date | 2009-02-03 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? | |
| P478 | volume | 100 |
| Q34632561 | A case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer Study |
| Q52936444 | Absence or low IGF-1R-expression in esophageal adenocarcinoma is associated with tumor invasiveness and radicality of surgical resection. |
| Q40444383 | Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population. |
| Q37398529 | Association of Barrett's esophagus with type II Diabetes Mellitus: results from a large population-based case-control study |
| Q36893433 | Association of insulin and insulin-like growth factors with Barrett's oesophagus. |
| Q37557505 | Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus |
| Q33646525 | CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis |
| Q38425601 | Case-control analysis on metformin and cancer of the esophagus. |
| Q55286544 | Decline in perception of acid regurgitation symptoms from gastroesophageal reflux disease in diabetes mellitus patients. |
| Q35923092 | Diabetes and risk of esophageal and gastric adenocarcinomas |
| Q93144923 | Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium |
| Q41622143 | Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis |
| Q84049962 | Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease |
| Q35893814 | Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma |
| Q39561604 | Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis |
| Q37831966 | Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. |
| Q36348405 | Meta‐analysis: the association of oesophageal adenocarcinoma with symptoms of gastro‐oesophageal reflux |
| Q35185711 | Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. |
| Q38248208 | Obesity and related risk factors in gastric cardia adenocarcinoma |
| Q34949732 | Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers |
| Q35622201 | Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence |
| Q53091526 | Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. |
| Q43493272 | Statin use is associated with a reduced incidence of colorectal adenomatous polyps |
| Q37662211 | The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study |
Search more.